Demystifying Moderna: Insights From 11 Analyst Reviews
Demystifying Moderna: Insights From 11 Analyst Reviews
揭秘moderna：11位分析师评测带来的洞见
In examining recent analyst actions, we gain...Analysts' ratings for Moderna (NASDAQ:MRNA) over the last quarter vary from bullish to bearish, as provided by 11 analysts.
11位分析师提供的分析师对Moderna（纳斯达克股票代码：MRNA）在上个季度的评级从看涨到看跌不等。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天中情绪的变化，并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $140.55, with a high estimate of $214.00 and a low estimate of $80.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 8.19%.
分析师对12个月目标股价的评估提供了更多见解，显示平均目标价为140.55美元，最高估计为214.00美元，最低估计为80.00美元。随着分析师将平均目标股价下调了8.19％，情绪的负面转变显而易见。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细明细
In examining recent analyst actions, we gain...
在研究分析师最...
登录免费看全文
登录/注册